01 1Formosa Laboratories, Inc.
02 1Hainan Poly Pharm. Co., Ltd.
03 1Jiangsu Hengrui Pharmaceuticals Co., Ltd.
04 1SIONC PHARMACEUTICALS PVT LTD
01 3Gadoterate Meglumine
02 1Gadoterate meglumine
01 2China
02 1India
03 1Taiwan
NDC Package Code : 66499-0066
Start Marketing Date : 2019-09-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14335-310
Start Marketing Date : 2022-05-31
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 57884-0037
Start Marketing Date : 2020-03-31
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 76055-1003
Start Marketing Date : 2022-12-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
58
PharmaCompass offers a list of Gadoterate Meglumine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Gadoterate Meglumine manufacturer or Gadoterate Meglumine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Gadoterate Meglumine manufacturer or Gadoterate Meglumine supplier.
PharmaCompass also assists you with knowing the Gadoterate Meglumine API Price utilized in the formulation of products. Gadoterate Meglumine API Price is not always fixed or binding as the Gadoterate Meglumine Price is obtained through a variety of data sources. The Gadoterate Meglumine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Gd-DOTA Meglumine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Gd-DOTA Meglumine, including repackagers and relabelers. The FDA regulates Gd-DOTA Meglumine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Gd-DOTA Meglumine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Gd-DOTA Meglumine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Gd-DOTA Meglumine supplier is an individual or a company that provides Gd-DOTA Meglumine active pharmaceutical ingredient (API) or Gd-DOTA Meglumine finished formulations upon request. The Gd-DOTA Meglumine suppliers may include Gd-DOTA Meglumine API manufacturers, exporters, distributors and traders.
click here to find a list of Gd-DOTA Meglumine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Gd-DOTA Meglumine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Gd-DOTA Meglumine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Gd-DOTA Meglumine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Gd-DOTA Meglumine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Gd-DOTA Meglumine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Gd-DOTA Meglumine suppliers with NDC on PharmaCompass.
We have 4 companies offering Gd-DOTA Meglumine
Get in contact with the supplier of your choice:
